Cambridge Nutritional Sciences PLC
LSE:CNSL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.4
4.35
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cambridge Nutritional Sciences PLC
Cambridge Nutritional Sciences PLC
Cost of Revenue
Cambridge Nutritional Sciences PLC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cambridge Nutritional Sciences PLC
LSE:CNSL
|
Cost of Revenue
-£3.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Cost of Revenue
-£2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Cost of Revenue
-$920m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Cost of Revenue
-£6.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
Inspecs Group PLC
LSE:SPEC
|
Cost of Revenue
-£99.7m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Cost of Revenue
-£59.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
Cambridge Nutritional Sciences PLC
Glance View
Cambridge Nutritional Sciences Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The firm develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The firm serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
See Also
What is Cambridge Nutritional Sciences PLC's Cost of Revenue?
Cost of Revenue
-3.7m
GBP
Based on the financial report for Mar 31, 2024, Cambridge Nutritional Sciences PLC's Cost of Revenue amounts to -3.7m GBP.
What is Cambridge Nutritional Sciences PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-10%
Over the last year, the Cost of Revenue growth was 7%. The average annual Cost of Revenue growth rates for Cambridge Nutritional Sciences PLC have been -10% over the past three years .
You don't have any saved screeners yet
